8-K current report · filed Aug 3, 2026

BIOLIFE SOLUTIONS INC (BLFS) 8-K Current Report: August 3, 2026

Item 7.01BLFS overview

Short answer

BIOLIFE SOLUTIONS INC (BLFS) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 7.01 (Regulation FD Disclosure). Repligen merger remains the central event, with BioLife slated to become a wholly owned Repligen subsidiary.

BIOLIFE SOLUTIONS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Repligen merger remains the central event, with BioLife slated to become a wholly owned Repligen subsidiary
  • August 3, 2026 employee video provides additional merger and Repligen information
  • Employee communications may support integration planning, but do not alter disclosed merger terms
  • Transaction remains subject to specified closing conditions and potential waivers

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other BIOLIFE SOLUTIONS INC 8-K filings

Get the next BLFS 8-K as it lands

Follow BLFS for push alerts, or ask the research agent what this filing means.